 | JNK Inhibitor V | IC50 | 70.0 [1], 120.0 [2] |
 | Jnk-IN-8 | IC50 | 0.98 [1], 1.0 [2], 338.0 [3], 486.0 [4] |
 | 1,9-Pyrazoloanthrone | IC50 | 90.0 [1], 190.0 [2] |
 | 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 290.0 [1], 790.0 [2] |
| 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole | Ki | 90.0 [1] |
 | Doramapimod | IC50 | 1400.0 [1], 10000.0 [2] |
 | N-(4-(2-(Phenylamino)pyridin-4-yl)pyridin-2-yl)-tetrahydrofuran-3-carboxamide | IC50 | 6.31 [1], 7.0 [2] |
 | 4-[3-(4-Fluorophenyl)-5-isopropylisoxazol-4-yl]pyridine | IC50 | 540.0 [1] |
 | Jnk-IN-7 | IC50 | 0.7 [1], 130.0 [2], 244.0 [3] |
 | N-[[5-[4-(Benzotriazol-1-yl)piperidin-1-yl]sulfonylthiophen-2-yl]methyl]-4-chlorobenzamide | IC50 | 150.0 [1] |
 | 4-[[(E)-4-(Dimethylamino)but-2-enoyl]amino]-N-[3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide | IC50 | 704.0 [1], 709.0 [2], 2400.0 [3] |
 | 3-[[(E)-4-(Dimethylamino)but-2-enoyl]amino]-N-[4-[[4-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide | IC50 | 0.5 [1], 9.0 [2], 48.0 [3] |
 | JNK Inhibitor VIII | Ki | 52.0 [1] |
 | Tanzisertib | IC50 | 6.0 [1] |
 | N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)benzamide | IC50 | 1500.0 [1], 1584.89 [2] |
 | N-Cyclohexyl-4-[5-(3,4-dichlorophenyl)-2-piperidin-4-yl-3-propylimidazol-4-yl]pyrimidin-2-amine | IC50 | 1.6 [1], 2.0 [2] |
 | 9-(4-Hydroxyphenyl)-2,7-phenanthroline | IC50 | 590.0 [1] |
 | 4-[5-(4-Fluorophenyl)-3-isopropylisoxazol-4-yl]pyridine | IC50 | 3500.0 [1] |
 | 3-{5-[(2-Fluorophenyl)amino]-1h-Indazol-1-Yl}-N-(3,4,5-Trimethoxyphenyl)benzamide | IC50 | 9.0 [1] |
 | CID 25222038 | IC50 | 148.0 [1] |
 | Methyl 6-bromo-2-[(4-methylsulfonylphenyl)methyl]-1-oxo-4-phenylisoquinoline-3-carboxylate | IC50 | 30.0 [1] |
 | 5-Methyl-N-(4-(2-(phenylamino)pyridin-4-yl)pyridin-2-yl)pyrazine-2-carboxamide | IC50 | 33.0 [1] |
 | N-(2-Methoxyphenyl)-3-phenyl-1H-indazol-6-amine | IC50 | 202.0 [1] |
 | N,3-Diphenyl-1H-indazol-6-amine | IC50 | 48.0 [1] |
 | 4-(6-(2-Chlorophenylamino)-1H-indazol-3-yl)-N-(2-(dimethylamino)ethyl)benzamide | IC50 | 1.9 [1] |
 | N-(4-Fluorophenyl)-4-(2-(4-fluorophenylamino)pyridin-4-yl)pyridin-2-amine | IC50 | 17.0 [1] |
 | N-(2-Methoxyphenyl)-4-(2-(2-methoxyphenylamino)pyridin-4-yl)pyridin-2-amine | IC50 | 528.0 [1] |
 | [(5S)-2-(4-Fluorophenyl)-3-[2-(propylamino)pyrimidin-4-yl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-5-yl]methanol | IC50 | 2.5 [1] |
 | Methyl 3-[2-(2-thienyl)acetamido]thiophene-2-carboxylate | IC50 | 2200.0 [1] |
 | N-[3-[4-(4-Fluorophenyl)-5-pyridin-4-ylimidazol-1-yl]propyl]benzamide | IC50 | 130.0 [1] |
 | 3-[6-(2-Chloro-phenylamino)-1H-indazol-3-yl]-N-piperidin-4-yl-benzamide | IC50 | 1.26 [1], 1.4 [2] |
 | 4-[(4-Phenylpyrimidin-2-yl)amino]benzamide | IC50 | 491.0 [1] |
| 4-[(4-Phenylpyrimidin-2-yl)amino]benzamide | Ki | 130.0 [1] |
 | N-(4-(2-(4-(1H-1,2,3-Triazol-1-yl)phenylamino)pyrimidin-4-yl)-phenyl)methanesulfonamide | IC50 | 4.0 [1] |
 | N-[4-Bromo-3-(1H-1,2,4-triazol-5-yl)thiophen-2-yl]-2-(2-oxo-3,4-dihydroquinolin-1-yl)acetamide | IC50 | 28.0 [1] |
 | 2-[5-(2-Chloroanilino)indazol-1-yl]-N-(2-morpholin-4-ylethyl)pyridine-4-carboxamide | IC50 | 120.0 [1] |
 | N-{2'-[(4-Fluorophenyl)amino]-4,4'-Bipyridin-2-Yl}-4-Methoxycyclohexanecarboxamide | IC50 | 15.0 [1], 235.0 [2] |
 | 3-[4-[(2-Chlorophenyl)carbamoylamino]pyrazol-1-yl]-N-(1-propan-2-ylpyrazol-4-yl)benzamide | IC50 | 114.0 [1], 3250.0 [2] |
 | 1-Ethyl-3-[4-[(7-oxo-8-propan-2-ylpyrido[2,3-d]pyrimidin-2-yl)amino]cyclohexyl]urea | IC50 | 37.0 [1], 57.0 [2] |
 | 3-[4-[(2-Chlorophenyl)carbamoylamino]pyrazol-1-yl]-N-(2,6-dimethylpyridin-4-yl)benzamide | IC50 | 130.0 [1], 2331.0 [2] |
 | 2-Methyl-N-[4-[(7-oxo-8-propan-2-ylpyrido[2,3-d]pyrimidin-2-yl)amino]cyclohexyl]propanamide | IC50 | 31.0 [1], 321.0 [2] |
 | 3-[4-[(2-Chlorophenyl)carbamoylamino]pyrazol-1-yl]-N-(1-piperidin-4-ylpyrazol-4-yl)benzamide | IC50 | 23.0 [1], 1436.0 [2] |
 | 3-[4-[(2-Chlorophenyl)carbamoylamino]pyrazol-1-yl]-N-[(6-methylpyridin-3-yl)methyl]benzamide | IC50 | 311.0 [1], 905.0 [2] |
 | 4-N-[4-[2-[4-(1H-Benzimidazol-2-ylamino)naphthalen-1-yl]oxypyridin-3-yl]pyrimidin-2-yl]cyclohexane-1,4-diamine | IC50 | 1.9 [1], 7.5 [2] |
 | 7-Chloro-1-(3,4-dichlorophenyl)-6-methoxy-3,4-dihydroisoquinoline | IC50 | 50.12 [1], 316.23 [2] |
 | 7-Chloro-1-(3-chlorophenyl)-6-methoxy-3,4-dihydroisoquinoline | IC50 | 125.89 [1], 251.19 [2] |
 | 2-[[5-Chloro-2-(2-methoxy-4-morpholin-4-ylanilino)pyridin-4-yl]amino]-N-methylbenzamide | IC50 | 83.0 [1] |
 | 3-[4-[(2-Chlorophenyl)carbamoylamino]pyrazol-1-yl]-N-(piperidin-4-ylmethyl)benzamide | IC50 | 206.0 [1], 1895.0 [2] |
 | 3-(4-{[(2-Chlorophenyl)carbamoyl]amino}-1h-Pyrazol-1-Yl)-N-(2-Methylpyridin-4-Yl)benzamide | IC50 | 98.0 [1], 866.0 [2] |
 | 2-[[5-Chloro-2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]amino]benzamide | IC50 | 0.28 [1], 0.3 [2] |
 | 2-[[5-Chloro-2-(2-methoxy-4-morpholin-4-ylanilino)pyrimidin-4-yl]amino]benzamide | IC50 | 0.78 [1], 0.8 [2] |
 | 2-[[5-Chloro-2-[4-(2-oxopyrrolidin-1-yl)anilino]pyrimidin-4-yl]amino]benzamide | IC50 | 0.16 [1] |
 | 2-(Benzo[d]thiazol-2-yl)-2-(2-(methylamino)pyrimidin-4-yl)acetonitrile | IC50 | 950.0 [1] |
 | Sotrastaurin | IC50 | 10000.0 [1] |
 | Neflamapimod | IC50 | 5000.0 [1] |
 | Cfms Receptor Tyrosine Kinase Inhibitor | IC50 | 16000.0 [1] |
 | 2-({5-Chloro-2-[(2-Methoxy-4-Morpholin-4-Ylphenyl)amino]pyrimidin-4-Yl}amino)-N-Methylbenzamide | IC50 | 12.0 [1] |
 | RepSox | IC50 | 16000.0 [1] |
 | Aminofurazanyl-azabenzimidazole 6n | IC50 | 10000.0 [1] |
 | 2-(2-(2-Methoxy-4-morpholinophenylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N-methylbenzamide | IC50 | 160.0 [1] |
 | CID 25182616 | IC50 | 2000.0 [1] |
 | TCS JNK 5a | IC50 | 199.53 [1] |
 | IKK-3 Inhibitor | IC50 | 15848.93 [1] |
 | 4-Methyl-3-(2-((2-morpholinoethyl)amino)quinazolin-6-yl)-N-(3-(trifluoromethyl)phenyl)benzamide | IC50 | 145.0 [1] |
 | CID 11634725 | Ki | 1400.0 [1] |
 | CID 59604787 | IC50 | 10000.0 [1] |
 | 6,7-Dimethoxy-1-phenyl-3,4-dihydroisoquinoline | IC50 | 15848.93 [1] |
 | CID 72547959 | IC50 | 364.0 [1] |
 | 1-(4-Chlorophenyl)-6,7-dimethoxy-3,4-dihydroisoquinoline | IC50 | 15848.93 [1] |
 | N-[4-[3-(6-Methylpyridin-3-yl)-1,2,4-triazol-1-yl]phenyl]-4-(3-morpholin-4-ylphenyl)pyrimidin-2-amine | IC50 | 159.0 [1] |
 | N-(3-Cyanophenyl)-2'-Methyl-5'-(5-Methyl-1,3,4-Oxadiazol-2-Yl)-4-Biphenylcarboxamide | IC50 | 16000.0 [1] |
 | 4-[[9-[(3R)-3-Oxolanyl]-8-(2,4,6-trifluoroanilino)-2-purinyl]amino]-1-cyclohexanol | IC50 | 32.0 [1] |
 | 8-N-(2,2-Dimethylpropyl)-2-N-[2-ethoxy-4-(4-methyl-1,2,4-triazol-3-yl)phenyl]-6-methylpyrido[3,4-d]pyrimidine-2,8-diamine | IC50 | 242.0 [1] |
 | 2-(4-Pyridinyl)-N-[3-(trifluoromethyl)phenyl]-1,3-thiazole-4-carboxamide | Ki | 13000.0 [1] |
 | N~3~-Cyclopropyl-N~4~'-(Cyclopropylmethyl)-6-Methylbiphenyl-3,4'-Dicarboxamide | IC50 | 16000.0 [1] |
 | 1-[3-(Trifluoromethyl)benzyl]-1H-indole-2,3-dione 3-oxime | Ki | 5200.0 [1] |
 | (3Z)-3-(Hydroxyimino)-1-[(4-methylphenyl)methyl]-2,3-dihydro-1H-indol-2-one | Ki | 9900.0 [1] |
 | 1-(3-Chlorobenzyl)-1H-indole-2,3-dione 3-oxime | Ki | 5000.0 [1] |
 | 1-(4-Chlorobenzyl)-1H-indole-2,3-dione 3-oxime | Ki | 6700.0 [1] |
 | CID 44814409 | IC50 | 10000.0 [1] |
 | N-(3-Cyano-4,5,6,7-Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide | IC50 | 398.11 [1] |
 | N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-2-(morpholin-4-yl)acetamide | IC50 | 15848.93 [1] |
 | Methyl 3-(2-(4-methoxyphenyl)acetamido)thiophene-2-carboxylate | IC50 | 1000.0 [1] |
 | 1-Benzyl-3-(hydroxyimino)indoline-2-one | Ki | 10000.0 [1] |
 | 5-Bromo-N-[3-chloro-2-(4-ethyl-1-piperazinyl)phenyl]-2-furamide | IC50 | 1100.0 [1] |
 | 4-Amino-5-cyano-6-ethoxy-N-[(4-methylsulfonylphenyl)methyl]pyridine-2-carboxamide | IC50 | 60.0 [1] |
 | 7-[[(16E)-14,19-Dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(24),2(27),3,5,8(26),9,11,16,21(25),22-decaen-11-yl]oxy]-N-hydroxyheptanamide | IC50 | 1000.0 [1] |
 | N-[3-Cyano-7-(cyclopropanecarbonyl)-5,6-dihydro-4H-thieno[2,3-b]pyridin-2-yl]naphthalene-1-carboxamide | IC50 | 251.19 [1] |
 | N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-4-fluoronaphthalene-1-carboxamide | IC50 | 1000.0 [1] |
 | N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-4-fluorobenzamide | IC50 | 3162.28 [1] |
 | N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-2-phenylacetamide | IC50 | 15848.93 [1] |
 | 2-(2-(Methylsulfinyl)benzylthio)-5-(4-fluorophenyl)-4-(pyridin-4-yl)pyrimidine | IC50 | 28500.0 [1] |
 | N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | Ki | 520.0 [1] |
 | Lck Inhibitor | IC50 | 7300.0 [1] |
 | 4-Amino-5-chloro-6-ethoxy-pyridine-2-carboxylic acid 4-methanesulfonyl-benzylamide | IC50 | 120.0 [1] |
 | [2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-7-yl]-[(3S)-3-aminopyrrolidin-1-yl]methanone | IC50 | 10000.0 [1] |
 | N-(Cyclopropylmethyl)-2'-Methyl-5'-(5-Methyl-1,3,4-Oxadiazol-2-Yl)biphenyl-4-Carboxamide | IC50 | 16000.0 [1] |
 | 1-(2,6-Dichlorophenyl)-5-(2,4-difluorophenyl)-7-(4-piperidinyl)-1,2,3,4-tetrahydroquinazoline-2-one | IC50 | 10000.0 [1] |
 | 4-[6-(Cyclopropylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N-[2-(dimethylamino)ethyl]benzamide | IC50 | 100000.0 [1] |
 | 2-Fluoro-6-[[2-[2-methoxy-4-(4-propan-2-ylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]benzamide | IC50 | 100.0 [1] |
Calculator
